An interventional study of Coach Pepper in Dementia, sponsored by Medical University of Graz. Completed at 1 site in Austria. Per ClinicalTrials.gov, last updated 2019-01-30.
Sponsored by Medical University of Graz · Not applicable, Interventional, and Supportive care
Background:
Dementia rates are increasing worldwide and consequently burden global healthcare resources to a serious degree. However, there is a declining number of caregivers to provide care. It is for this reason that many new technologies, such as socially assistive robots, have been developed because of their potential to support caregivers in promoting the independence of people with dementia. Most of the (socially assistive) robots have so far been tested for people without dementia in mainly laboratory or institutional settings, like nursing homes. Consequently, there is a lack of knowledge about the possible uses of robots from the perspective of those affected by dementia in real-life/care situations (e.g. at home). Testing in a laboratory setting cannot capture the complexity and high variability of everyday situations occurring during the care of persons with dementia.
Methods
The design is a mixed method intervention study of a refined socially assistive humanoid robot. In total, three people with dementia, three relatives, three dementia trainers and three professional caregivers were included in the study. Quantitative data of technology acceptance were collected using the "Technology Usage Inventory". Qualitative data (main focus: experiences with the robot and handling the robot) were collected by means of observation and qualitative interviews. Movement data of people with dementia were collected by means of the eye camera of the robot.
This study helps to further refine and test a socially assistive robot for people with dementia living at home.
2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.
This study's enrollment of 12 is below the median of 83 across 1,629 interventional studies indexed under Dementia.
Browse Dementia studies →Medical University of Graz is the lead sponsor of 459 studies on the registry; 98 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Persons with dementia:
Relatives:
Professional caregivers
Dementia trainers
ExclusioncCriteria:
Persons with dementia:
Pepper is a humanoid socially assistive robot
Device: Coach Pepper
Robot Peppers's height is 1.20 meters and it weighs 28 kilograms. Pepper will be called Coach Pepper, because it is connected, via web interfaces, with a theratainment app including cognitive and physical training
Technology acceptance (all participants): "Technology Usage Inventory"
The questionnaire "Technology Usage Inventory" measures technology acceptance. It captures technology-specific and psychological factors contributing to the use of a technological device. The questionnaire has 8 dimensions (curiosity:4 items, anxiety:4 items, interest:4 items, usability/user-friendliness: 3 items, immersion:4 items, utility:4 items, skepticism:4 items and accessibility:3 items) with 30 items (7-point Likert scale). For every dimension 1- 21 or 28 points can be obtained. For all dimensions, higher levels on the respective dimension indicate a higher level of expression in the respective construct.
Time frame: 1 week
Experience with the robot (all participants)
Qualitative interviews with people with dementia. 1 qualitative focus group interview for all other participants.
Time frame: 1 week
Handling the robot (people with dementia)
Open, 1-hour semi-structured participant observation of people with dementia using the robot at home conducted by nurses.
Time frame: After 3 days of intervention
Change of mobility (people with dementia)
Movement data collected by the eye camera of the robot.
Time frame: 1 week
Plan to share: Undecided
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Graz